Active Surveillance for low risk prostate cancer. Session proposed by ESO
Why do we need Active Surveillance? The problem of overdiagnosis, indolent cancer and overtreatment
Date
07 Oct 2016Session
Active Surveillance for low risk prostate cancer. Session proposed by ESOPresenters
Monique RoobolAuthors
M. RoobolAuthor affiliations
- Erasmus University Medical Center, Rotterdam/NL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
What do we need to improve the selection and management? Genetic profiling and serum markers
Presenter: Anders Bjartell
Session: Active Surveillance for low risk prostate cancer. Session proposed by ESO
Resources:
Slides
Webcast
Living with an untreated cancer. The quality of life of men on Active Surveillance
Presenter: Lara Bellardita
Session: Active Surveillance for low risk prostate cancer. Session proposed by ESO
Resources:
Slides
Webcast